Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Argyro G. Fragkaki
Observed names:
A. Fragkaki,
A. G. Fragkaki,
A.G Fragkaki,
A.G. Fragkaki,
Argyro Fragkaki
Institutions:
National Centre of Scientific Research "Demokritos",
Hellenic Open University,
Institute of Biosciences & Applications
Observed institutions:
National and Kapodistrian University of Athens,
National Centre of Scientific Research "Demokritos",
Hellenic Open University,
Olympic Athletic Center of Athens "Spiros Louis",
Institute of Biosciences & Applications
ORCID:
0000-0002-9422-670X
Observed ORCID:
0000-0002-9422-670X
OpenAlex ID:
A5084893708
Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities
2008
·
A.G. Fragkaki
, Y.S. Angelis
, et al.
·
Steroids
·
163
Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine
2009
·
A.G. Fragkaki
, Y.S. Angelis
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
66
An overview of the doping control analysis during the Olympic Games of 2004 in Athens, Greece
2005
·
M. Tsivou
, N. Kioukia-Fougia
, et al.
·
Analytica Chimica Acta
·
60
Statistical analysis of fragmentation patterns of electron ionization mass spectra of enolized-trimethylsilylated anabolic androgenic steroids
2009
·
A.G. Fragkaki
, Y.S. Angelis
, et al.
·
International Journal of Mass Spectrometry
·
56
Identifying risk management challenges in laboratories
2023
·
Evdoxia Tziakou
, Argyro G. Fragkaki
, et al.
·
Accreditation and Quality Assurance
·
55
PDF
Comparison of sulfo‐conjugated and gluco‐conjugated urinary metabolites for detection of methenolone misuse in doping control by LC‐HRMS, GC‐MS and GC‐HRMS
2015
·
A. G. Fragkaki
, Y. S. Angelis
, et al.
·
Journal of Mass Spectrometry
·
48
Human in vivo metabolism study of LGD‐4033
2018
·
Argyro G. Fragkaki
, Panagiotis Sakellariou
, et al.
·
Drug Testing and Analysis
·
47
Advances in The Detection of Designer Steroids in Anti-Doping
2014
·
Wadha Abushareeda
, Argyro Fragkaki
, et al.
·
Bioanalysis
·
42
Sports doping: Emerging designer and therapeutic β2-agonists
2013
·
A.G. Fragkaki
, C. Georgakopoulos
, et al.
·
Clinica Chimica Acta
·
40
Gas chromatographic quantitative structure–retention relationships of trimethylsilylated anabolic androgenic steroids by multiple linear regression and partial least squares
2009
·
A.G. Fragkaki
, A. Tsantili-Kakoulidou
, et al.
·
Journal of Chromatography A
·
40
Challenges in detecting substances for equine anti‐doping
2017
·
A. G. Fragkaki
, N. Kioukia‐Fougia
, et al.
·
Drug Testing and Analysis
·
38
PDF
Comparison of multiple linear regression, partial least squares and artificial neural networks for prediction of gas chromatographic relative retention times of trimethylsilylated anabolic androgenic steroids
2012
·
A.G. Fragkaki
, E. Farmaki
, et al.
·
Journal of Chromatography A
·
32
Quantitative structure–retention relationship study of α-, β1-, and β2-agonists using multiple linear regression and partial least-squares procedures
2004
·
A.G Fragkaki
, M.A Koupparis
, et al.
·
Analytica Chimica Acta
·
32
Markers of mesterolone abuse in sulfate fraction for doping control in human urine
2015
·
P. Kiousi
, Y. S. Angelis
, et al.
·
Journal of Mass Spectrometry
·
21
Modeling and prediction of trihalomethanes in the drinking water treatment plant of Thessaloniki, Greece
2021
·
C. Albanakis
, E. Tsanana
, et al.
·
Journal of Water Process Engineering
·
20
Liquid chromatography–mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes
2021
·
Polyxeni Kiousi
, Argyro G. Fragkaki
, et al.
·
Drug Testing and Analysis
·
20
Organization of the doping control laboratory in the Athens 2004 Olympic Games: A case study
2005
·
A.G. Fragkaki
, I.-P. Leontiou
, et al.
·
Technovation
·
15
Determination of anabolic androgenic steroids as imidazole carbamate derivatives in human urine using liquid chromatography–tandem mass spectrometry
2020
·
Argyro G. Fragkaki
, Georgia Petropoulou
, et al.
·
Journal of Separation Science
·
14
LC‐MS/(MS) confirmatory doping control analysis of intact phase II metabolites of methenolone and mesterolone after Girard's Reagent T derivatization
2023
·
Yiannis S. Angelis
, Argyro G. Fragkaki
, et al.
·
Drug Testing and Analysis
·
10
PDF
Alternative markers for Methylnortestosterone misuse in human urine
2020
·
Panagiotis Sakellariou
, Polyxeni Kiousi
, et al.
·
Drug Testing and Analysis
·
10
New long‐standing metabolites of 17α‐methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine
2023
·
Yiannis S. Angelis
, Panagiotis Sakellariou
, et al.
·
Drug Testing and Analysis
·
8
PDF
Determination of salmeterol, α ‐hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC–QTOF–MS
2021
·
Panagiotis Sakellariou
, Michael Petrou
, et al.
·
Biomedical Chromatography
·
5
A Synopsis of the Adverse Analytical and Atypical Findings Between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece
2013
·
Nassia Kioukia-Fougia
, Argyro Fragkaki
, et al.
·
Journal of Analytical Toxicology
·
3
Human in vivo metabolism study of LGD‐4033
2019
·
Argyro G. Fragkaki
, Panagiotis Sakellariou
, et al.
·
Drug Testing and Analysis
·
2
PDF
Embedding Lean Principles and Digital Transformation into Organizational Culture: Effects on Industry 4.0 Adoption and Corporate Sustainability Performance—A Case Study in Metal Processing
2026
·
Pantelis Baxevanidis Taros
, Maria Gianni
, et al.
·
Lecture notes in production engineering
Show more works
View as search
Works count:
25
Citation count:
847
H-index:
16
I10-index:
20
Year
Topic
Type